Access the full text.
Sign up today, get DeepDyve free for 14 days.
Kamran Sajadi, M. Terris, R. Hamilton, J. Cullen, C. Amling, C. Kane, J. Presti, W. Aronson, S. Freedland (2007)
Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy.The Journal of urology, 178 3 Pt 1
M. Tollefson, B. Leibovich, J. Slezak, H. Zincke, M. Blute (2006)
Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.The Journal of urology, 175 2
G. Hall, Charles Kramer, J. Epstein (1992)
Evaluation of Radical Prostatectomy Specimens: A Comparative Analysis of Sampling MethodsThe American Journal of Surgical Pathology, 16
A. D'Amico, Richard Whittington, S. Malkowicz, D. Schultz, John Tomaszewski, A. Wein (1999)
A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer.Urology, 52 4
S. Freedland, C. Amling, F. Dorey, C. Kane, J. Presti, M. Terris, W. Aronson (2002)
Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.Urology, 60 4
J. Imperato-McGinley, T. Gautier, K. Zirinsky, T. Hom, O. Palomo, E. Stein, E. Vaughan, J. Markisz, E. Arellano, E. Kazam (1992)
Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency.The Journal of clinical endocrinology and metabolism, 75 4
C. King, J. Long (2000)
Prostate biopsy grading errors: A sampling problem?International Journal of Cancer, 90
N. Petrelli, J. Abbruzzese, P. Mansfield, B. Minsky (2005)
Hepatic resection: the last surgical frontier for colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 20
J. Garnett, Ryoichi Oyasu, J. Grayhack (1984)
The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens.The Journal of urology, 131 4
G. Kulkarni, R. Al-azab, G. Lockwood, A. Toi, A. Evans, J. Trachtenberg, M. Jewett, A. Finelli, N. Fleshner (2006)
Evidence for a biopsy derived grade artifact among larger prostate glands.The Journal of urology, 175 2
S. Lerner, M. Blute, E. Bergstralh, D. Bostwick, J. Eickholt, H. Zincke (1996)
Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.The Journal of urology, 156 1
W. Horninger, Hermann Rogatsch, A. Reissigl, H. Volgger, H. Klocker, A. Hobisch, G. Bartsch (1999)
Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA‐based screeningThe Prostate, 40
A. Partin, J. Oesterling, J. Epstein, R. Horton, P. Walsh (1991)
Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.The Journal of urology, 145 2
Charlotte Foley, Simon Bott, K. Thomas, M. Parkinson, Roger Kirby (2003)
A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency ratesBJU International, 92
A. D'Amico, R. Whittington, S. Malkowicz, D. Schultz, A. Renshaw, J. Tomaszewski, J. Richie, A. Wein (1999)
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.International journal of radiation oncology, biology, physics, 45 5
P. Sved, P. Gómez, M. Manoharan, Sandy Kim, M. Soloway (2004)
Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer.The Journal of urology, 172 1
J. Hammarsten, B. Högstedt (2001)
Hyperinsulinaemia as a Risk Factor for Developing Benign Prostatic HyperplasiaEuropean Urology, 39
S. Freedland, W. Isaacs, E. Platz, M. Terris, W. Aronson, C. Amling, J. Presti, C. Kane (2005)
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 30
R. Turley, R. Hamilton, M. Terris, C. Kane, W. Aronson, J. Presti, C. Amling, S. Freedland (2008)
Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database.The Journal of urology, 179 2
R. Hamilton, W. Aronson, J. Presti, M. Terris, C. Kane, C. Amling, S. Freedland (2007)
Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomyCancer, 110
A. Tewari, R. Indudhara, K. Shinohara, E. Schalow, Mitchell Woods, R. Lee, C. Anderson, P. Narayan (1996)
Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasiaJournal of Clinical Ultrasound, 24
P. Marker, A. Donjacour, R. Dahiya, G. Cunha (2003)
Hormonal, cellular, and molecular control of prostatic development.Developmental biology, 253 2
R. Roberts, E. Bergstralh, J. Cunningham, S. Hebbring, S. Thibodeau, M. Lieber, S. Jacobsen (2004)
Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia.American journal of epidemiology, 159 3
J. Imperato-McGinley, R. Peterson (1976)
Male pseudohermaphroditism: the complexities of male phenotypic development.The American journal of medicine, 61 2
A. Gregori, J. Vieweg, P. Dahm, D. Paulson (2001)
Comparison of Ultrasound-Guided Biopsies and Prostatectomy Specimens: Predictive Accuracy of Gleason Score and Tumor SiteUrologia Internationalis, 66
S. Freedland, C. Kane, C. Amling, W. Aronson, M. Terris, J. Presti (2006)
Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.Urology, 69 3
W. Kassouf, H. Nakanishi, A. Ochiai, Kara Babaian, P. Troncoso, R. Babaian (2007)
Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.The Journal of urology, 178 1
C. King, J. McNeal, H. Gill, J. Presti (2004)
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.International journal of radiation oncology, biology, physics, 59 2
A. D'Amico, Andrew Renshaw, Leisa Arsenault, D. Schultz, Jerome Richie (1999)
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy.International journal of radiation oncology, biology, physics, 45 4
D’Amico (1999)
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapyInt J Radiat Oncol Biol Phys, 45
A. Briganti, F. Chun, N. Suardi, A. Gallina, J. Walz, M. Graefen, S. Shariat, A. Ebersdobler, P. Rigatti, P. Perrotte, F. Saad, F. Montorsi, H. Huland, P. Karakiewicz (2007)
Prostate volume and adverse prostate cancer features: fact not artifact.European journal of cancer, 43 18
P. Emiliozzi, S. Maymone, A. Paterno, P. Scarpone, M. Amini, G. Proietti, M. Cordahi, V. Pansadoro (2004)
Increased accuracy of biopsy Gleason score obtained by extended needle biopsy.The Journal of urology, 172 6 Pt 1
OBJECTIVE To test the hypothesis that the association between prostate size and risk of Gleason grade upgrading varies as a function of sampling. PATIENTS AND METHODS We examined the association between pathological prostate weight, prostate biopsy scheme and Gleason upgrading (Gleason ≥7 at radical prostatectomy, RP) among 646 men with biopsy Gleason 2–6 disease treated with RP between 1995 and 2007 within the Shared Equal Access Regional Cancer Hospital Database using logistic regression. In all, 204 and 442 men had a sextant (six or seven cores) or extended‐core biopsy (eight or more cores), respectively. Analyses were adjusted for centre, age, surgery, preoperative prostate‐specific antigen level, clinical stage, body mass index, race, and percentage of cores positive for cancer. RESULTS In all, 281 men (44%) were upgraded; a smaller prostate was positively associated with the risk of upgrading in men who had an extended‐core biopsy (P < 0.001), but not among men who had a sextant biopsy (P = 0.22). The interaction between biopsy scheme and prostate size was significant (P interaction = 0.01). CONCLUSIONS These data support the hypothesis that the risk of upgrading is a function of two opposing contributions: (i) a more aggressive phenotype in smaller prostates and thus increased risk of upgrading; and (ii) more thorough sampling in smaller prostates and thus decreased risk of upgrading. When sampled more thoroughly, the phenotype association dominates and smaller prostates are linked with an increased risk of upgrading. In less thoroughly sampled prostates, these opposing factors nullify, resulting in no association between prostate size and risk of upgrading. These findings help to explain previously published disparate results of the importance of prostate size as a predictor of Gleason upgrading.
BJU International – Wiley
Published: Nov 1, 2008
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.